{
  "id": 3943820,
  "title": "BioXcel Therapeutics Agrees To Teva Asset Sale",
  "url": "https://urgent.news/2026/08/28/bioxcel-therapeutics-agrees-to-teva-asset-sale",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-28T10:22:50.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/bioxcel-therapeutics-agrees-teva-asset-sale"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - BioXcel Therapeutics Inc. (BTAI) on Friday entered into an agreement to sell substantially all of its assets to Teva Pharmaceuticals International GmbH (TEVA.TA) and filed for voluntary Chapter 11 bankruptcy.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}